Karyopharm Therapeutics Inc (KPTI)

Mar 03, 2026

Tax-driven share sale by Karyopharm (KPTI) EVP Mano Michael disclosed - Stock Titan

Mar 03, 2026

Mar 03, 2026

Karyopharm (NASDAQ: KPTI) EVP sells shares for tax withholding - Stock Titan

Mar 03, 2026

Mar 03, 2026

Karyopharm (KPTI) EVP executes automatic share sale for tax withholding - Stock Titan

Mar 03, 2026

Mar 03, 2026

Karyopharm (KPTI) CEO executes automatic 12,361-share sale to cover RSU taxes - Stock Titan

Mar 03, 2026

Mar 03, 2026

Automatic tax-sale trims Karyopharm (NASDAQ: KPTI) EVP shareholdings - Stock Titan

Mar 03, 2026

Mar 03, 2026

Karyopharm Therapeutics Inc. 8-K Filing and Material Definitive Agreement (February 27, 2026) - Minichart

Mar 03, 2026

Mar 03, 2026

KPTI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026

Mar 03, 2026

Karyopharm Therapeutics Incon February 27, 2026, company enters second amendment to Credit AgreementSEC filing - marketscreener.com

Mar 03, 2026

Mar 03, 2026

Karyopharm Amends Credit Agreement to Extend Liquidity Runway - TipRanks

Mar 03, 2026

Mar 03, 2026

According to a filing submitted to the U.S. Securities and Exchange Commission (SEC), Karyopharm Therapeutics Inc. has obtained permission through an amended agreement to defer the payment deadline for certain amounts until September 2026. - Bitget

Mar 03, 2026

Mar 03, 2026

Karyopharm Therapeutics Amends Credit Agreement to Defer 2026 Payments, Tied to $25M Equity Raise - TradingView

Mar 03, 2026

Mar 03, 2026

[Form 4] Karyopharm Therapeutics Inc. Insider Trading Activity - Stock Titan

Mar 03, 2026

Mar 02, 2026

Karyopharm (KPTI) debt relief and forbearance depend on $25M stock sale - Stock Titan

Mar 02, 2026

Mar 02, 2026

Karyopharm Grants 1,450 RSUs to New Hires - National Today

Mar 02, 2026

Mar 02, 2026

Pharma company Karyopharm gives 1,450 stock units to two new hires - Stock Titan

Mar 02, 2026

Mar 02, 2026

Karyopharm (KPTI) Q4 2025 Earnings Call Transcript - AOL.com

Mar 02, 2026

Feb 28, 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Sees Significant Increase in Short Interest - MarketBeat

Feb 28, 2026

Feb 26, 2026

Karyopharm Therapeutics Target of Unusually Large Options Trading (NASDAQ:KPTI) - MarketBeat

Feb 26, 2026

Feb 25, 2026

KPTI Should I Buy - Intellectia AI

Feb 25, 2026

Feb 23, 2026

Karyopharm Therapeutics Shareholders Approve Plan to Nearly Double Authorized Shares at Special Meeting - Yahoo Finance

Feb 23, 2026

Feb 23, 2026

Earnings call transcript: Karyopharm sees 11.8% revenue rise in Q4 2025 - Investing.com Nigeria

Feb 23, 2026

Feb 23, 2026

New Highs: Should I set a stop loss on NVAXEarnings Growth Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn

Feb 23, 2026

Feb 20, 2026

HC Wainwright Brokers Lift Earnings Estimates for KPTI - MarketBeat

Feb 20, 2026

Feb 20, 2026

Can Karyopharm Therapeutics Inc. disrupt its industryJuly 2025 Price Swings & Stepwise Trade Signal Guides - mfd.ru

Feb 20, 2026

Feb 19, 2026

Karyopharm Shareholders Approve Major Authorized Share Increase - TipRanks

Feb 19, 2026

Feb 19, 2026

KPTI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 19, 2026

Feb 19, 2026

Wall Street Analysts Believe Karyopharm Therapeutics (KPTI) Could Rally 56.06%: Here's is How to Trade - Zacks Investment Research

Feb 19, 2026

Feb 18, 2026

HC Wainwright Reaffirms "Buy" Rating for Karyopharm Therapeutics (NASDAQ:KPTI) - MarketBeat

Feb 18, 2026

Feb 18, 2026

KPTI Receives Reiterated "Buy" Rating from HC Wainwright & Co. | - GuruFocus

Feb 18, 2026

Feb 17, 2026

Registration Momentum Builds Across the Oncology Pipeline - GlobeNewswire

Feb 17, 2026

Feb 17, 2026

T. Rowe Price reports 11.8% Karyopharm Therapeutics (KPTI) stake - Stock Titan

Feb 17, 2026

Feb 15, 2026

Aug Movers: Can Karyopharm Therapeutics Inc disrupt its industry2025 Retail Activity & Low Drawdown Momentum Ideas - baoquankhu1.vn

Feb 15, 2026

Feb 15, 2026

Analyst Estimates: Here's What Brokers Think Of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) After Its Full-Year Report - 富途牛牛

Feb 15, 2026

Feb 15, 2026

Analysts Have Made A Financial Statement On Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) Annual Report - Yahoo Finance

Feb 15, 2026

Feb 14, 2026

Karyopharm Earnings Call: Pivotal Data Amid Cash Squeeze - The Globe and Mail

Feb 14, 2026

Feb 14, 2026

Is Karyopharm Therapeutics Inc.’s growth already priced in2025 Market Outlook & Daily Profit Focused Stock Screening - mfd.ru

Feb 14, 2026

Feb 14, 2026

Karyopharm Therapeutics Faces Rising Regulatory and Political Risks Amid Supreme Court Limits on FDA Authority - TipRanks

Feb 14, 2026

Feb 14, 2026

Karyopharm Therapeutics to Announce Q4 Earnings on February 12 - Intellectia AI

Feb 14, 2026

Feb 13, 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 13, 2026

Feb 13, 2026

Karyopharm Therapeutics Inc. SEC 10-K Report - TradingView

Feb 13, 2026

Feb 13, 2026

Karyopharm Q4 2025 slides: Revenue growth amid pivotal myelofibrosis readout preparations - Investing.com Australia

Feb 13, 2026

Feb 12, 2026

Karyopharm Therapeutics Inc Shares Rise After Q4 2025 Results - AlphaStreet News

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics Inc (KPTI) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst ... By GuruFocus - Investing.com Canada

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics Inc (KPTI) Q4 2025 Earnings Call Highlig - GuruFocus

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics Q4 Earnings Call Highlights - MarketBeat

Feb 12, 2026

Feb 12, 2026

Karyopharm reports fourth quarter and full year 2025 financial results and highlights recent company progress - marketscreener.com

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics (NASDAQ:KPTI) Releases Earnings Results - MarketBeat

Feb 12, 2026

Feb 12, 2026

Page not foundAirwhon - MarketBeat

Feb 12, 2026

Feb 12, 2026

KPTI: Q4 revenue up, operating loss improved, pivotal phase 3 data in myelofibrosis due soon - TradingView

Feb 12, 2026